166 related articles for article (PubMed ID: 27604324)
1. A Partial E3 Deletion in Replication-Defective Adenoviral Vectors Allows for Stable Expression of Potentially Toxic Transgene Products.
Haut LH; Gill AL; Kurupati RK; Bian A; Li Y; Giles-Davis W; Xiang Z; Zhou XY; Ertl HC
Hum Gene Ther Methods; 2016 Oct; 27(5):187-196. PubMed ID: 27604324
[TBL] [Abstract][Full Text] [Related]
2. Effects of the deletion of early region 4 (E4) open reading frame 1 (orf1), orf1-2, orf1-3 and orf1-4 on virus-host cell interaction, transgene expression, and immunogenicity of replicating adenovirus HIV vaccine vectors.
Thomas MA; Song R; Demberg T; Vargas-Inchaustegui DA; Venzon D; Robert-Guroff M
PLoS One; 2013; 8(10):e76344. PubMed ID: 24143187
[TBL] [Abstract][Full Text] [Related]
3. Construction and characterization of E1- and E3-deleted adenovirus vectors expressing two antigens from two separate expression cassettes.
Small JC; Kurupati RK; Zhou X; Bian A; Chi E; Li Y; Xiang Z; Ertl HC
Hum Gene Ther; 2014 Apr; 25(4):328-38. PubMed ID: 24367921
[TBL] [Abstract][Full Text] [Related]
4. Attenuation of Replication-Competent Adenovirus Serotype 26 Vaccines by Vectorization.
Maxfield LF; Abbink P; Stephenson KE; Borducchi EN; Ng'ang'a D; Kirilova MM; Paulino N; Boyd M; Shabram P; Ruan Q; Patel M; Barouch DH
Clin Vaccine Immunol; 2015 Nov; 22(11):1166-75. PubMed ID: 26376928
[TBL] [Abstract][Full Text] [Related]
5. Development of oncolytic and gene therapy vectors based on adenovirus serotype 4 as an alternative to adenovirus serotype 5.
Sallard E; Schulte L; van den Boom A; Klimovitskii A; Knierer J; Hagedorn C; Knocks M; Zhang W; Kreppel F; Ehrhardt A; Ehrke-Schulz E
J Gene Med; 2024 Jan; 26(1):e3576. PubMed ID: 37580111
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the E3 and L3 regions for arming oncolytic adenoviruses to achieve a high level of tumor-specific transgene expression.
Robinson M; Ge Y; Ko D; Yendluri S; Laflamme G; Hawkins L; Jooss K
Cancer Gene Ther; 2008 Jan; 15(1):9-17. PubMed ID: 17853920
[TBL] [Abstract][Full Text] [Related]
7. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.
Nanda D; Vogels R; Havenga M; Avezaat CJ; Bout A; Smitt PS
Cancer Res; 2001 Dec; 61(24):8743-50. PubMed ID: 11751394
[TBL] [Abstract][Full Text] [Related]
8. Antibody responses to prime-boost vaccination with an HIV-1 gp145 envelope protein and chimpanzee adenovirus vectors expressing HIV-1 gp140.
Emmer KL; Wieczorek L; Tuyishime S; Molnar S; Polonis VR; Ertl HC
AIDS; 2016 Oct; 30(16):2405-2414. PubMed ID: 27525550
[TBL] [Abstract][Full Text] [Related]
9. Preventing spontaneous genetic rearrangements in the transgene cassettes of adenovirus vectors.
Cottingham MG; Carroll F; Morris SJ; Turner AV; Vaughan AM; Kapulu MC; Colloca S; Siani L; Gilbert SC; Hill AV
Biotechnol Bioeng; 2012 Mar; 109(3):719-28. PubMed ID: 22252512
[TBL] [Abstract][Full Text] [Related]
10. Development of a recombinant adenovirus vector production system free of replication-competent adenovirus by utilizing a packaging size limit of the viral genome.
Suzuki T; Sasaki T; Yano K; Sakurai F; Kawabata K; Kondoh M; Hayakawa T; Yagi K; Mizuguchi H
Virus Res; 2011 Jun; 158(1-2):154-60. PubMed ID: 21470569
[TBL] [Abstract][Full Text] [Related]
11. Construction and characterization of E1-minus replication-defective adenovirus vectors that express E3 proteins from the E1 region.
Toth K; Kuppuswamy M; Doronin K; Doronina O; Lichtenstein D; Tollefson A; Wold W
Virology; 2002 Sep; 301(1):99-108. PubMed ID: 12359450
[TBL] [Abstract][Full Text] [Related]
12. Cochlear function and transgene expression in the guinea pig cochlea, using adenovirus- and adeno-associated virus-directed gene transfer.
Luebke AE; Foster PK; Muller CD; Peel AL
Hum Gene Ther; 2001 May; 12(7):773-81. PubMed ID: 11339894
[TBL] [Abstract][Full Text] [Related]
13. Protease-deleted adenovirus vectors and complementing cell lines: potential applications of single-round replication mutants for vaccination and gene therapy.
Oualikene W; Lamoureux L; Weber JM; Massie B
Hum Gene Ther; 2000 Jun; 11(9):1341-53. PubMed ID: 10890743
[TBL] [Abstract][Full Text] [Related]
14. Effect of HIV-1 envelope cytoplasmic tail on adenovirus primed virus encoded virus-like particle immunizations.
Andersson AC; Ragonnaud E; Seaton KE; Sawant S; Folgori A; Colloca S; Labranche C; Montefiori DC; Tomaras GD; Holst PJ
Vaccine; 2016 Oct; 34(44):5344-5351. PubMed ID: 27633665
[TBL] [Abstract][Full Text] [Related]
15. Modulation of the inflammatory properties and hepatotoxicity of recombinant adenovirus vectors by the viral E4 gene products.
Christ M; Louis B; Stoeckel F; Dieterle A; Grave L; Dreyer D; Kintz J; Ali Hadji D; Lusky M; Mehtali M
Hum Gene Ther; 2000 Feb; 11(3):415-27. PubMed ID: 10697116
[TBL] [Abstract][Full Text] [Related]
16. Transgene amplification and persistence after delivery of retroviral vector and packaging functions with E1/E4-deleted adenoviruses.
Torrent C; Jullien C; Klatzmann D; Perricaudet M; Yeh P
Cancer Gene Ther; 2000 Aug; 7(8):1135-44. PubMed ID: 10975674
[TBL] [Abstract][Full Text] [Related]
17. Adenoviral vectors for in vivo gene delivery to oligodendrocytes: transgene expression and cytopathic consequences.
Franklin Rm; Quick Mm; Haase G
Gene Ther; 1999 Aug; 6(8):1360-7. PubMed ID: 10467360
[TBL] [Abstract][Full Text] [Related]
18. Production and characterization of improved adenovirus vectors with the E1, E2b, and E3 genes deleted.
Amalfitano A; Hauser MA; Hu H; Serra D; Begy CR; Chamberlain JS
J Virol; 1998 Feb; 72(2):926-33. PubMed ID: 9444984
[TBL] [Abstract][Full Text] [Related]
19. Adenovirus gene transfer vectors inhibit growth of lymphatic tumor metastases independent of a therapeutic transgene.
Korst RJ; Ailawadi M; Lee JM; Lee S; Yamada R; Mahtabifard A; Crystal RG
Hum Gene Ther; 2001 Sep; 12(13):1639-49. PubMed ID: 11535167
[TBL] [Abstract][Full Text] [Related]
20. AdEasy-based cloning system to generate tropism expanded replicating adenoviruses expressing transgenes late in the viral life cycle.
Lie-A-Ling M; Bakker CT; Wesseling JG; Bosma PJ
Gene Ther; 2005 Sep; 12(17):1347-52. PubMed ID: 15877046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
